Tag Archives: NYSE:MRK

US Stock Market Movers Roundup: Merck, Bristol Myers Squibb, NewLink Genetics, Pandora, Apple, Google, Microsoft

Posted on June 4, 2013 by Thomas Vedder

Merck & Co, Inc’s (NYSE:MRK) stock hiked over 3.5% after its experimental medicine shrank tumors in a promising number of skin-cancer patients in a clinical inquiry, the most recent milestone for an emerging crop of therapies that unleash the body’s …

Posted in Latest Headlines, Services | Tagged AAPL, Apple, BMY, Bristol-Myers Squibb, GOOG, Google, Merck, Microsoft, MRK, MSFT, NASDAQ:AAPL, nasdaq:goog, NASDAQ:MSFT, NASDAQ:NLNK, NewLink Genetics, NLNK, NYSE:BMY, NYSE:MRK, NYSE:P, P, Pandora Media | Comments Off

US Stock Market Potential Movers: Blackstone, Rio Tinto, Merck, Express Scripts, Goldman Sachs, Morgan Stanley, Citigroup

Posted on June 3, 2013 by Thomas Vedder

Private-equity Company The Blackstone Group LP (NYSE:BX) and Glencore Xstrata PLC are among the suitors mulling over acquiring Rio Tinto plc (ADR) (NYSE:RIO) Canadian iron-ore operations, as shown in the report by Dow Jones Newswires.

The Blackstone Group L.P. (NYSE:BX) …

Posted in Latest Headlines, Services | Tagged Blackstone, BX, C, Citigroup NYSE:C, ESRX, Express Scripts, Goldman Sachs, GS, Merck, Morgan Stanley, MRK, MS, NASDAQ:ESRX, NYSE:BX, NYSE:GS, NYSE:MRK, NYSE:MS, NYSE:RIO, RIO, Rio Tinto | Comments Off

Hot Stocks News Review: Titan Machinery, Nordson, Aeropostale, Campbell Soup, Merck

Posted on May 25, 2013 by Thomas Vedder

Titan Machinery Inc (NASDAQ:TITN) unveiled preliminary fiscal Q1 results lower than analyst forecasts. The equipment retailer reported revenue was below it had forecasted in its agriculture and construction units.

Titan Machinery Inc. (NASDAQ:TITN) last session’s volume of 2.83 million shares …

Posted in Latest Headlines, Services | Tagged Aeropostale, ARO, Campbell Soup, CPB, Merck, MRK, NASDAQ:NDSN, NASDAQ:TITN, NDSN, Nordson, NYSE:ARO, NYSE:CPB, NYSE:MRK, Titan Machinery, TITN | Comments Off

Inovio Pharmaceuticals (NYSE:INO) Loss Widens in Fiscal First Quarter – INO, MRK, PPHM, PFE

Posted on May 13, 2013 by Thomas Vedder

Inovio Pharmaceuticals Inc (NYSE:INO) on Friday announced fiscal Q1 net loss was $8.86 million or $0.06 per share, evaluated against $8.3 million or $.06 per share in previous year.

Revenue for three months period plunged to $1.5 million from $1.7 …

Posted in Healthcare, Latest Headlines, Latest Picks | Tagged INO, Inovio Pharmaceuticals, Merck, MRK, NASDAQ:PPHM, NYSE:INO, NYSE:MRK, NYSE:PFE, Peregrine Pharmaceuticals, PFE, Pfizer, PPHM | Comments Off

Healthcare Sector Roundup: Covance (NYSE:CVD), Merck (NYSE:MRK) – CVD, MRK, PFE, AGN, ASTX, REGN

Posted on May 2, 2013 by Thomas Vedder

Healthcare sector finished lower on Tuesday’s trading session and sector tumbled -1.13%. If we consider at the best movers of the sector so Allergan, Inc (NYSE:AGN) and Astex Pharmaceuticals, Inc (NASDAQ:ASTX) were major percentage decliners while key percentage gainer was …

Posted in Healthcare, Latest Headlines | Tagged AGN, Allergan, Astex, ASTX, Covance, CVD, Merck, MRK, NASDAQ:ASTX, NASDAQ:REGN, NYSE:AGN, NYSE:CVD, NYSE:MRK, NYSE:PFE, PFE, Pfizer, Regeneron, REGN | Comments Off

Quick Roundup of Potential U.S. Stock Market Movers: General Motors (NYSE:GM), Merck (NYSE:MRK)

Posted on May 1, 2013 by Thomas Vedder

stock market 2 General Motors Company (NYSE:GM) announced on Wednesday a 11 percent boost in April United States vehicle sales.

United States auto maker sold 237,646 pick-ups and cars in this period, bringing its seasonally adjusted yearly rate of sales to 15 million.…

Posted in Latest Headlines | Tagged General Motors, GM, Merck & Co., MRK, NYSE:GM, NYSE:MRK | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.